Ariana Thacker

Ariana Thacker, the CEO of MoldCo and a leading expert on mold-related health issues, shares her eye-opening journey battling toxic mold exposure. She discusses the serious health impacts of mold, the emotional toll it takes on individuals, and the inadequacies of traditional medical testing. Ariana emphasizes the importance of recognizing symptoms early and exploring innovative treatments. She reveals her insights on creating mold-free living environments and the need for better awareness about mold toxicity as a public health concern.

Sam Ross, CEO of Numeral, shares insights on automating sales tax for e-commerce, emphasizing AI's role in compliance. Aaron Slodov of Atomic Industries discusses revitalizing U.S. manufacturing through tech innovation and upcoming Detroit expansions. Pippa Lamb highlights significant U.S. tech investments in the UK as the country aims for AI leadership under PM Keir Starmer. Ariana Thacker from MoldCo talks about transforming care for mold-related illnesses after her personal experience, supported by their recent $8M funding. Meanwhile, Will Hurd explores advancements in defense technology.

Ariana Thacker, chemical engineer and CEO of MoldCo who rebuilt her life after toxic mold exposure. She explains mold as a systemic, cellular illness. Topics include how mold drives inflammation, hormone and mitochondrial disruption, genetic susceptibility, home dust testing, diagnostic pathways, and why treatment must pair medical care with environmental remediation.

Ariana Thacker, cofounder and CEO of Moldco, shares her journey from personal mold-related illness to developing a virtual clinic for effective treatment. She discusses the overlooked nature of mold illnesses, highlighting genetic susceptibility and the chronic impacts of exposure. Ariana explains her three-step clinical protocol and the importance of treating the majority first. Additionally, she addresses how mold can affect mental health, metabolism, and the need for greater public awareness, all while sharing insights on scaling healthcare solutions in the mold space.

In this engaging conversation, Ariana Thacker, the founder and CEO of MoldCo, shares her journey from personal mold toxicity struggles to creating a groundbreaking healthcare platform. She discusses the wide-reaching impact of mold exposure on millions of Americans and highlights the challenges within traditional healthcare systems. Ariana emphasizes the importance of evidence-based solutions like the Shoemaker protocol while navigating the complexities of raising capital for her innovative startup. Her passion for patient-centered care shines through as she aims to transform mold-related healthcare.